Severity
Low
FDA Drug recall · Reported April 9, 2014
Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point
Teva Pharmaceuticals USA recalled QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mkt… - a low-severity action.
QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mkt… was recalled by Teva Pharmaceuticals USA in April 9, 2014. Reason: Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point. Check the official notice for the remedy. Verify recall #D-1190-2014 with the FDA Drug before acting.
The recall
Teva Pharmaceuticals USA issued this low-severity FDA Drug recall-Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point.
Sourced from official FDA Drug enforcement records. Verify recall #D-1190-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1190-2014) was formally reported on April 9, 2014, with the manufacturer initiating the action on February 11, 2014. It is classified under Low severity (Class III), with a current status of Terminated. Teva Pharmaceuticals USA is listed as the recalling firm, operating out of Horsham, PA. Federal records list the affected scope as 257,832 cylinders.
The documented reason for this recall is: Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
257,832 cylinders
Related Recalls
6
5 from same agency
QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Horsham, PA 19044 Mfd by: 3M Drug Delivery Systems, Northridge, CA 91324.
Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1190-2014 |
| Date reported | April 9, 2014 |
| Date initiated | February 11, 2014 |
| Recalling firm | Teva Pharmaceuticals USA |
| Firm location | Horsham, PA |
| Affected scope | 257,832 cylinders |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 9, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.